- Home
- AMPH vs PTA Comparison
AMPH vs PTA Comparison
Compare AMPH & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- PTA
- Stock Information
- Founded
- AMPH 1996
- PTA 2020
- Country
- AMPH United States
- PTA United States
- Employees
- AMPH N/A
- PTA N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- PTA Trusts Except Educational Religious and Charitable
- Sector
- AMPH Health Care
- PTA Finance
- Exchange
- AMPH Nasdaq
- PTA Nasdaq
- Market Cap
- AMPH 1.2B
- PTA 1.2B
- IPO Year
- AMPH 2014
- PTA N/A
- Fundamental
- Price
- AMPH $24.39
- PTA $19.90
- Analyst Decision
- AMPH Buy
- PTA
- Analyst Count
- AMPH 6
- PTA 0
- Target Price
- AMPH $35.50
- PTA N/A
- AVG Volume (30 Days)
- AMPH 369.0K
- PTA 159.2K
- Earning Date
- AMPH 11-06-2025
- PTA 01-01-0001
- Dividend Yield
- AMPH N/A
- PTA 8.31%
- EPS Growth
- AMPH N/A
- PTA N/A
- EPS
- AMPH 2.68
- PTA N/A
- Revenue
- AMPH $722,679,000.00
- PTA N/A
- Revenue This Year
- AMPH $1.00
- PTA N/A
- Revenue Next Year
- AMPH $6.74
- PTA N/A
- P/E Ratio
- AMPH $9.15
- PTA N/A
- Revenue Growth
- AMPH 1.37
- PTA N/A
- 52 Week Low
- AMPH $20.39
- PTA $15.84
- 52 Week High
- AMPH $53.96
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- AMPH 40.87
- PTA 38.62
- Support Level
- AMPH $22.94
- PTA $19.69
- Resistance Level
- AMPH $24.87
- PTA $20.00
- Average True Range (ATR)
- AMPH 0.79
- PTA 0.27
- MACD
- AMPH 0.12
- PTA -0.05
- Stochastic Oscillator
- AMPH 42.90
- PTA 22.73
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.